首頁 › 黃斑部病變 › 德克薩斯州 › The Woodlands
The Woodlands, TX 的 黃斑部病變 臨床試驗
9 項針對 黃斑部病變 的研究正在 The Woodlands（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
招募中2/3 期
- Retina Consultants of Texas (Site 014), The Woodlands
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
招募中2/3 期
- Retina Consultants of Texas, The Woodlands
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
招募中3 期
- Retina Consultants Texas, The Woodlands
Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
招募中2 期
- Retina Consultants of Texas, The Woodlands
Intravitreal (IVT) Pozelimab for Geographic Atrophy (GA) in Adult Participants
招募中1 期
- Retina Consultants Texas, The Woodlands
Ixoberogene Soroparvovec (Ixo-vec) Contralateral Dosing Study in Participants With Neovascular Age-related Macular Degeneration
招募中2 期
- Adverum site 107, The Woodlands
- Adverum site 231, The Woodlands
Study to Assess the Adverse Events and How Intravitreal ABBV-6628 Moves Through the Body of Adult Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
招募中1/2 期
- Retina Consultants - The Woodlands /ID# 262138, The Woodlands
Phase 1b/2a Study of EYC-0305 in Patients With Neovascular Age-related Macular Degeneration
招募中1/2 期
- The Woodlands, TX, The Woodlands
Age-Related Macular Degeneration Benchmark Imaging Dataset (ABID)
招募中觀察性研究歡迎健康志工
- Retina Consultants of Texas (Houston), The Woodlands
其他城市的 黃斑部病變 試驗
- Dallas, TX13 項研究
- Erie, PA10 項研究
- Reno, NV8 項研究
- Sacramento, CA8 項研究
- Hagerstown, MD8 項研究
- Cleveland, OH7 項研究
- Fort Worth, TX7 項研究
- Houston, TX7 項研究
- Carmel, IN7 項研究
- Salt Lake City, UT7 項研究
- Austin, TX7 項研究
- Phoenix, AZ7 項研究
The Woodlands 的其他研究
- 非小細胞肺癌15 項研究
- 肥胖症12 項研究
- 過重10 項研究
- 乳癌10 項研究
- 心血管疾病9 項研究
- 轉移性癌症9 項研究
- 第二型糖尿病7 項研究
- 心臟衰竭7 項研究
- 肺癌7 項研究
- 動脈硬化6 項研究
- 地圖樣萎縮6 項研究
- 前列腺癌6 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。